Lexicon Pharmaceuticals (LXRX) EPS (Basic) (2010 - 2026)
Lexicon Pharmaceuticals' (LXRX) quarterly EPS (Basic) came in at -$0.01 in Q1 2026, up 83.28% year-on-year from -$0.01 in Q1 2025, and up 71.42% on a QoQ basis from -$0.05 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) EPS (Basic) (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 17 years of EPS (Basic) data on file, last reported at -$0.01 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 83.28% year-over-year to -$0.01 in Q1 2026; TTM through Mar 2026 was -$0.11, a 79.86% increase from a year earlier, with the FY2025 full-year figure at -$0.17, up 91.36% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.01, up from -$0.05 in the prior quarter.
- Over the last five years, EPS (Basic) for LXRX reached as high as -$0.01 in Q2 2025 and fell as low as -$0.25 in Q2 2023.
- Historically, EPS (Basic) has averaged -$0.14 across 5 years, with a median of -$0.17 in 2023.
- Across the five-year window, EPS (Basic) tumbled 76.2% in 2023 and surged 93.8% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$0.19 in 2022, then fell by 25.2% to -$0.24 in 2023, then jumped by 48.97% to -$0.12 in 2024, then soared by 61.53% to -$0.05 in 2025, then surged by 71.42% to -$0.01 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.01 in Q1 2026, -$0.05 in Q4 2025, and -$0.05 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Lexicon Pharmaceuticals | 922.55 Mn | 751.90 Mn | 20.99 Mn | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01 |
| Dec 31, 2025 | -0.05 |
| Sep 30, 2025 | -0.05 |
| Jun 30, 2025 | -0.01 |
| Mar 31, 2025 | -0.08 |
| Dec 31, 2024 | -0.12 |
| Sep 30, 2024 | -0.19 |
| Jun 30, 2024 | -0.19 |
| Mar 31, 2024 | -0.20 |
| Dec 31, 2023 | -0.24 |
| Sep 30, 2023 | -0.24 |
| Jun 30, 2023 | -0.25 |
| Mar 31, 2023 | -0.17 |
| Dec 31, 2022 | -0.19 |
| Sep 30, 2022 | -0.14 |
| Jun 30, 2022 | -0.17 |
| Mar 31, 2022 | -0.16 |
| Dec 31, 2021 | -0.17 |
| Sep 30, 2021 | -0.16 |
| Jun 30, 2021 | -0.13 |